Sponsor
Articles matching:
Your Unread Messages in Urology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Delay in referral for abnormal PSA associated with disease progression
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Clinical Pearls for Urologists
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
1 Surgical castration for androgen-deprivation therapy of prostate cancer – relevance in current practice Journal of Clinical Urology, April 2, 2013
2 A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy The Journal of Urology, April 8, 2013
3 Low serum testosterone levels are predictive of prostate cancer World Journal of Urology, April 9, 2013
4 Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study Prostate Cancer & Prostatic Diseases, April 11, 2013
5 Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States The Journal of Urology, April 18, 2013
6 Associations of tea and coffee consumption with prostate cancer risk Cancer Causes and Control, April 22, 2013
7 Randomized controlled trial to assess the efficacy of the combination therapy of alfuzosin and tadalafil in patients with lower urinary tract symptoms due to benign prostatic hyperplasia LUTS: Lower Urinary Tract Symptoms, April 5, 2013
8 Androgen annihilation as a new therapeutic paradigm in advanced prostate cancer Current Opinion in Urology, April 8, 2013 Review Article
9 Morbidity of focal therapy in the treatment of localized prostate cancer European Urology, April 1, 2013 Free full text
10 Is lycopene an effective agent for preventing prostate cancer? Cancer Prevention Research, March 14, 2013 Review Article
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor